Should patients with high-risk prostate cancer receive 6 months or 3 years of adjuvant androgen suppression therapy?
Year: 2007
Type: article
Source: Nature Clinical Practice Urology
DOI: 10.1038/ncpuro0932
Authors: Seth Strope, David P Wood
Institutions: University of Michigan, Michigan Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1986879358
